September 20, 2017
In order to realize the estimated $11.4 billion in savings, the Centers for Medicare and Medicaid Services would need to revise the way it currently reimburses for biosimilar drugs.
 
September 18, 2017

Jim Loerop with lead the company's business development and mergers and acquisitions functions as the company ramps up its move into the complex generics and specialty branded segments.

September 18, 2017

The acne treatment had U.S. sales of roughly $57 million for the 12 months ended July 2017, Perrigo said.

September 14, 2017

Mvasi, a biosimilar of Avastin, is indicated to treat five types of cancer. 

September 14, 2017

The drug had U.S. sales of $44.1 million for the 12 months ended June 2017, according to QuintilesIMS data.

September 14, 2017

The product had U.S. sales of roughly $346.9 million for the 12 months ended July 31, according to QuintilesIMS data.

September 12, 2017

The legislation aims to make it easier for generics makers to access drug samples of branded products when trying to develop a generic version, many of which are protected by Risk Evaluation and Management Strategies,

September 11, 2017

The drug had U.S. sales of $149.9 million for the 12 months ended June 2017, according to QuintilesIMS data.

September 11, 2017

Kåre Schultz Schultz has had a nearly 30-year career in the pharmaceutical and healthcare industries, including a long stint at Novo Nordisk, where he eventually became COO. 

September 8, 2017
The approval means that Admelog has met all requirements for the regulatory agency, pending any patent issues that have not yet been resolved. 
September 7, 2017

The two drugs had combined brand and generic sales of approximately $893 million, according to data from QunitilesIMS for the 12 months ended July 2017. 

September 5, 2017
The drug had brand and generic sales of approximately $50.5 million for the 12 months ended June 2017, according to QuntilesIMS data.
September 5, 2017
The product had an estimated market size of $122.4 million, according to QuintilesIMS data for the 12 months ended June 2017. 
September 5, 2017

Lupin’s generic will be available in 5-, 20- and 40-mg dosage strengths.

September 5, 2017

The company has named its current global head of drug development and chief medical officer, Dr. Vasant Narasimhan, as CEO, effective Feb. 1, 2018.

August 29, 2017

The patents relative to Restasis are listed in the Orange Book and expire on Aug. 27, 2024, Allergan stated.

August 29, 2017

A United States appeals court has revived an antitrust lawsuit against four drug makers, alleging that they hamstrung generics for Lipitor and Effexor XR.

August 29, 2017

Cyltezo will be available as 40mg/0.8mL strength pre-filled glass syringes in 2-count cartons.

August 29, 2017

Researchers found that women with high cholesterol were 45% less likely to develop breast cancer than those without high cholesterol, suggesting their treatment for high cholesterol may be a factor.

August 24, 2017

The product had brand and generic sales of roughly $484.4 million for the 12 months ended June 2017, according to QuintilesIMS data.

August 22, 2017

Oseltamivir capsules began shipping July 11 from Amneal's Glasgow, Ky., distribution center and can be purchased through major wholesalers and distributors.

August 22, 2017

The savings report, published by the AAM in June, highlighted the importance competition in the generics market plays in driving down costs.

August 22, 2017

Camber Pharmaceuticals on Monday awarded Walgreens Boots Alliance in recognition of its status as the No. 1 trading partner for 2016-2017.

August 22, 2017

Testosterone topical solution CIII is a prescription medicine used to treat adult males who have low or no testosterone due to certain medical conditions.